Source: Virtual Congress 2020 – Reflections from the Lung Science 2020 conference
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
S. Cloonan (New York City, United States of America). Mitochondrial iron in the susceptibility, pathogenesis and progression of COPD. Virtual Congress 2020 – Reflections from the Lung Science 2020 conference

Member's Comments

No comment yet.

Related content which might interest you: PARK2-regulated mitophagy in COPD pathogenesis Source: International Congress 2017 – Novel molecular and genetic targets in COPD Year: 2017 Defective metabolic adaptation in the pathogenesis of COPD Source: International Congress 2019 – Metabolic alterations as a driver of chronicity in lung disease Year: 2019 Lysosomal dysfunction in COPD pathogenesis. Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD Year: 2019 Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019 Year: 2020 Involvement ferroptosis in COPD pathogenesis Source: International Congress 2017 – Cigarette smoke and particulate matter: basic science and clinical aspects Year: 2017 Mitochondrial dysfunction in chronic lung disease Source: International Congress 2016 – Dysfunctional mitochondria in respiratory disease Year: 2016 Mechanisms of development oxidative stress and progression chronic respiratory failure in patients with COPD Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic Year: 2009 PP108 – Role of TRIM-16-mediated lysophagy in COPD pathogenesis Source: ERS Lung Science Conference 2021 Year: 2021 Rate of progression of lung function impairment in α1-antitrypsin deficiency Source: Eur Respir J 2009; 33: 1338-1344 Year: 2009 Dysregulated mitochondrial integrity associated with lamin B1 reduction is involved in cellular senescence progression in COPD pathogenesis. Source: International Congress 2018 – New kids on the block: novel molecular pathways and therapeutic targets in chronic lung diseases Year: 2018 Role of Parkin in the pathogenesis of COPD-related sarcopenia Source: International Congress 2019 – New molecular signatures in COPD, lung cancer and a1-antitrypsin deficiency Year: 2019 DNA damage as a molecular link in the pathogenesis of COPD in smokers Source: Eur Respir J 2012; 39: 1368-1376 Year: 2012 Plasma mitochondrial DNA as a biomarker of disease progression in idiopathic pulmonary fibrosis Source: International Congress 2018 – Novel insights in the basic and translational research on idiopathic interstitial pneumonias Year: 2018 Iron deficiency as a novel biomarker of functional impairment in patients with chronic obstructive pulmonary disease (COPD) Source: Annual Congress 2011 - Physiological basis of respiratory disease Year: 2011 Role of necroptosis in the pathogenesis of COPD Source: International Congress 2019 – Mechanisms underlying acute exacerbation of respiratory disease Year: 2019 Identification of oxidative stress markers and their association with inflammation in smokers and early chronic obstructive pulmonary disease (COPD) Source: International Congress 2016 – Hospitalisation and comorbidities in chronic lung diseases Year: 2016 Extracellular nucleotides contribute to the pathogenesis of viral-induced exacerbations in COPD via P2X4/P2X7-receptor activation Source: International Congress 2019 – Mechanisms underlying respiratory infection Year: 2019 Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease Source: Eur Respir J 2004; 23: 629-636 Year: 2004 Age-dependent systemic elastin degradation is enhanced in chronic obstructive pulmonary disease Source: International Congress 2016 – New signalling pathways in COPD Year: 2016 Virus-induced ²vicius circles² of COPD pathogenesis Source: Eur Respir J 2004; 24: Suppl. 48, 409s Year: 2004